Biotech from the ground up

Lactobio is a world leading probiotic and microbiome research company located in Copenhagen, Denmark.


Søren Kjærulff, Founder & Chief Executive Officer

CEO of Lactobio and also a co-founder of Fermbiotics. Former Senior Director of Biopharma R&D at Novozymes AS, responsible for leading biology research within anti-infection and anti-inflammation.

Holds Ph.D. in molecular biology from University of Copenhagen and is author of several peer-reviewed papers and inventor of several granted patents.

Charlotte Vedel, Founder & Chief Operating Officer

COO of Lactobio and former CTO of Novo Nordisk Foundation Center for Biosustainability. Formerly Vice President of IP, DuPont Nutrition & Health and has longterm experience as R&D manager and scientist in microbiology and antimicrobial compounds.

Holds a Ph.D. in microbiology from the Danish Technical University and is author of several peer-reviewed papers and inventor of several granted patents.

Janus Rasmussen, Chief Commercial Officer

CCO at Lactobio. Janus is an experienced Business executive with plus 20 years’ experience from top CPG global NYSE company, with an entrepreneurial, commercial, strategic and people-orientated mindset. Proven track-record of transforming and developing organizations and portfolio into new impactful revenue-streams. Disrupting the market while maintaining current
business for a fluent transformation.


Steen Riisgaard, Chairman of the Board

Steen Riisgaard is an investor in Lactobio and serves as Chairman of the board. Steen Riisgard is the former CEO of Novozymes.

Other board positions:

• Novo Holdings A/S
• New Xelia Group A/S
• Villum Foundation
• Novo Nordisk Foundation
• Corbion
• University of Aarhus

Per Falholt, Board member

Per Falholt is a board member and investor in Lactobio. Per Falholt is the former CSO and EVP of Novozymes.

Other board positions:

• Universe A/S
• DHI Foundation
• Danfoss A/S.

Thomas G. Schmidt, Board member

Thomas is a board member and investor in Lactobio and the current CEO of 21st Bio.

• Senior Partner at McKinsey holding multiple leadership positions over 25+ years
• Serving global clients in biotech, pharma and agriculture
• Lived and worked in Europe, The US and Latin America
• Inspired, driven and visionary

Niels Zibrandtsen, Board member

Niels Zibrandtsen was one of the significant players in the 1990’s, when the Danish tele monopoly was broken and paved the way for new business based on innovative telecommunication solutions and the ability to execute.

Niels Zibrandtsen early saw the opportunities and established the telecommunications company GlobalConnect, which offered the business market a new, fast fiber-based data infrastructure and the first wireless connection across Øresund.

The foundation for success was laid, and the big thoughts that were behind the company’s name turned out to hold true. The sale of GlobalConnect – 20 years later – enabled Niels Zibrandtsen to have the freedom to invest more in the DNA he has always believed in; people who think fundamentally different and therefore can see opportunities and solutions no-one else can see. Today Niels Zibrandtsen and his family have built up a family-owned investment company, Zibra A/S. Zibra was created to invest smart money in innovative business ideas and people who executes, change, and improve the world